Ultrasound-Guided Breast Biopsy Market to Witness a Pronounce Growth During 2019-2029

FMI logo

Ultrasound-Guided Breast Biopsy: Market Insights

Breast cancer is one of the leading cause of cancer in women affecting nearly 80% of women over 50 years of age. Breast cancer mostly starts either with the breast tissue which is made up of glands for milk production know as lobules or in the ducts. Abnormalities or lumps in breast are mostly detected by mammography or physical examination and other imaging techniques. Thus, ultrasound-guided breast biopsy was introduced into the market which is performed by taking some abnormality samples by guidance from MRI or mammography, ultrasound. In ultrasound-guided breast biopsy, radiologist used ultrasound imaging to guide to the site of abnormal growth of the cells. An ultrasound-guided breast biopsy is mostly performed when there occurs an abnormality such as distortion in the structure of the breast tissue, suspicious mass of solid and area of change of abnormal tissue. According to World Health Organization, an estimate of 627,000 women died from breast cancer in 2018 globally. Thus with increasing prevalence of breast cancer, ultrasound-guided breast biopsy is likely to spur the growth of the market.

Request For Report Sample @https://www.futuremarketinsights.com/reports/sample/rep-gb-9580

Ultrasound-Guided Breast Biopsy: Market Dynamics

Ultrasound-guided breast biopsy is expected to manifest significant growth in the market due to its less invasive than other surgical biopsy. In addition to this, ultrasound-guided breast biopsy leaves little scar and can be performed in in very less time which as a result will increase the adoption rate of ultrasound-guided breast biopsy. Apart from this, no ionizing radiation is used in ultrasound-guided breast biopsy imaging and also provide faster results which is likely to drive the growth of the ultrasound-guided breast biopsy market. Moreover the ultrasound-guided breast biopsy is less expensive and has less recovery time. All this factor will contribute to the growth of the ultrasound-guided breast biopsy market. However, there are certain limitation in restraining the growth of the ultrasound-guided breast biopsy market. Certain factors such as risk of bleeding that forms hematoma may appear during biopsy. In addition to this, patients may find discomfort during the biopsy which in turn may affect the growth of the ultrasound-guided breast biopsy market. Cost of instrument is also another important factor in restraining the growth of the market.

Ultrasound-Guided Breast Biopsy Market: Segmentation

The global ultrasound-guided breast biopsy market is segmented by procedure types and end user.

  • Segmentation by Procedure
    • Fine needle aspiration (FNA) ultrasound-guided breast biopsy
    • Core needle (CN) ultrasound-guided breast biopsy
    • Vacuum-assisted device (VAD) ultrasound-guided breast biopsy
    • Wire localization ultrasound-guided breast biopsy
  • Segmentation by End User
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Others

Ultrasound-Guided Breast Biopsy Market: Overview

Ultrasound-guided breast biopsy is anticipate to boost the growth of the market. With the increasing prevalence and incidences of breast cancer, the ultrasound-guided breast biopsy is likely to witness significant growth in the ultrasound-guided breast biopsy market. Manufactures are now currently focused on developing new imaging devices for proper treatment of breast cancer. Since it provides results in less time and lessen the duration of patients stay, ultrasound-guided breast biopsy is gaining much popularity among other methods and thus ultrasound-guided breast biopsy will spur the growth of the market.

Ultrasound-Guided Breast Biopsy Market: Region-wise Outlook

On the basis of geography, the global ultrasound-guided breast biopsy market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is expected to witness considerable growth in ultrasound-guided breast biopsy market owing to rising adoption of new technologies, increase in launch of new imaging systems and high healthcare infrastructure is likely to foster the growth of the ultrasound-guided breast biopsy market. Europe is expected to register significant growth in ultrasound-guided breast biopsy market due to rising prevalence of breast cancer and advancement of technologies will significantly foster the growth of the ultrasound-guided breast biopsy market. Asia Pacific has shown significant potential in accelerating the growth of the ultrasound-guided breast biopsy market due to increasing campaigns about breast cancer in providing awareness among people for early diagnosis and treatment is likely to boost the growth of ultrasound-guided breast biopsy market. Japan also seems to have considerable growth in the ultrasound-guided breast biopsy market due to increasing advancement in research and development, growing prevalence of breast cancer is anticipate to generate revenue for ultrasound-guided breast biopsy market. Middle East and Africa has witness less growth in ultrasound-guided breast biopsy market due to poor healthcare infrastructure and economy in the region which may hamper the growth of ultrasound-guided breast biopsy market.

Request For Report Table of Content (TOC):https://www.futuremarketinsights.com/toc/rep-gb-9580

Ultrasound-Guided Breast Biopsy Market: Key Players

Some of the key players present across the value chain of the global ultrasound-guided breast biopsy market are Hologic, Inc., Medsurge Ind Private Limited

Be the first to comment

Leave a Reply

Your email address will not be published.


*